Connect with us

Technology

Scientific Instrument Market size is set to grow by USD 19.96 billion from 2024-2028, Increasing investments in drug discovery boost the market, Technavio

Published

on

NEW YORK, July 31, 2024 /PRNewswire/ — The global scientific instrument market size is estimated to grow by USD 19.96 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 5.45% during the forecast period. Increasing investments in drug discovery is driving market growth, with a trend towards growing adoption of portable scientific instruments. However, lack of trained professionals poses a challenge. Key market players include ABB Ltd., ACMAS Technologies Pvt. Ltd., Agilent Technologies Inc., Alcon Scientific, Bio Rad Laboratories Inc., Bruker Corp., Carl Zeiss AG, Danaher Corp., Hitachi Ltd., HORIBA Ltd., Labappara, M.K.Scientific Instruments, MAC, Merck KGaA, Oxford Instruments plc, Shimadzu Corp., SM Scientific Instruments Pvt. Ltd., Thermo Fisher Scientific Inc., Thorlabs Inc., and Waters Corp..

Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report

Scientific Instrument Market Scope

Report Coverage

Details

Base year

2023

Historic period

2018 – 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 5.45%

Market growth 2024-2028

USD 19966.9 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

4.77

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 34%

Key countries

US, China, Germany, UK, and India

Key companies profiled

ABB Ltd., ACMAS Technologies Pvt. Ltd., Agilent Technologies Inc., Alcon Scientific, Bio Rad Laboratories Inc., Bruker Corp., Carl Zeiss AG, Danaher Corp., Hitachi Ltd., HORIBA Ltd., Labappara, M.K.Scientific Instruments, MAC, Merck KGaA, Oxford Instruments plc, Shimadzu Corp., SM Scientific Instruments Pvt. Ltd., Thermo Fisher Scientific Inc., Thorlabs Inc., and Waters Corp.

 

Market Driver

The scientific instrument market is experiencing a significant shift towards miniaturized and portable equipment due to the need for space efficiency and convenience in laboratory settings. Vendors are redesigning industry-standard instruments using miniaturization technologies such as fluidics and integrated printed circuit boards (PCBs) to create compact versions of laboratory equipment. Traditional scientific instruments often have complex wiring and components at the bottom and rear, but miniaturization allows for the removal of these elements, making the equipment more compact. Advancements in sensors and wireless connectivity further enable the creation of portable instruments, freeing them from the need for complex wires and cables. Integration of multiple laboratory functions and features onto a single chip through very large-scale integration technologies also saves money, space, and manpower for both vendors and end-users. Miniaturization and nanotechnology have revolutionized point-of-care testing and led to the manufacturing of portable equipment like miniaturized centrifuges from companies such as Bio-Rad Laboratories, Thermo Fisher Scientific, and Merck. These portable analyzers offer quick decision-making capabilities with advanced technologies like X-ray fluorescence (XRF), near-infrared (NIR), Raman, and Fourier transform infrared spectroscopy (FTIR), and an easy-to-use interface. The benefits of miniaturized and portable scientific instruments are driving their demand, and this trend is expected to continue during the forecast period. 

The Scientific Instruments market is thriving, driven by trends in various sectors. Product microscopes, spectrometers, X-ray diffraction, thermal analyzers, and other lab equipment are in high demand. Handheld and portable instruments are popular for field research in healthcare companies, retail sales, and online sales. Biotechnology, materials science, environmental science, private organizations, and academic institutions are major buyers. Electron microscopes, mass spectrometers, DNA sequencers, particle accelerators, and molecular analyzers are key tools for precision medicine, genetic sequencing, drug development, and molecular interactions. Biomarker detection systems, drug safety, and automated solutions are essential for disease mechanisms research in genomics and proteomics. Pharmaceutical companies, analytical instruments manufacturers, startups, and research institutions are investing heavily in this sector. Trends include portable instruments, data analysis, drug safety, and solutions for chronic and target diseases. 

Discover 360° analysis of this market. For complete information, schedule your consultation – Book Here!

Market Challenges

The scientific instrument market is experiencing significant technological advancements at an accelerated pace. Keeping up-to-date with these changes and maintaining a workforce with advanced technical skills is a challenge for end-users due to the high costs of training. Calibration of scientific instruments is crucial for accurate results, yet line inspectors may not possess the necessary technical capabilities. Additionally, interpreting data from these instruments and effectively handling accompanying software requires specialized knowledge. The scarcity of professionals with both medical expertise and software proficiency, coupled with frequent software upgrades and increasing instrument features, poses a critical challenge to the growth of the global scientific instrument market.The Scientific Instrument Market faces several challenges in various sectors. In the healthcare industry, accurate measurement and analysis of urine, tissue, glucose levels, cholesterol levels, and blood cell counts are crucial for medical diagnosis and treatment planning. Infectious diseases, cancer, and chronic conditions like diabetes, respiratory diseases, and cardiovascular diseases require advanced diagnostic tools. Clinical laboratories and hospitals rely on clinical analyzers for quick and accurate results. The biotech and pharmaceutical research sectors need instruments for measuring physical quantities, remodeling, and theoretical research. In the pharmaceutical sectors, verifying the efficacy of therapeutics is essential. Public health emergencies require rapid diagnostic tools for outpatients and inpatients. The research segment focuses on developing instruments for mutated diseases and neurological diseases. Laboratory automation is a key trend to improve efficiency and reduce errors. Overall, meeting the demands of these sectors while ensuring accuracy, reliability, and affordability is a significant challenge for the Scientific Instrument Market.

For more insights on driver and challenges – Request a sample report!

Segment Overview 

This scientific instrument market report extensively covers market segmentation by

Product 1.1 Laboratory analytical instruments and consumables1.2 Measuring and monitoring devicesEnd-user 2.1 Pharmaceutical and biotechnology companies2.2 Hospitals and diagnostic laboratories2.3 OthersGeography 3.1 North America3.2 Europe3.3 Asia3.4 Rest of World (ROW)

1.1 Laboratory analytical instruments and consumables- The global scientific instrument market’s laboratory analytical instruments and consumables segment encompasses mass spectrometers, chromatographs, and other tools that assist in diagnosing and analyzing specific infections. These instruments are extensively utilized in life science research, particularly in metabolomics, genomics, and proteomics, employing spectroscopy, mass spectrometry, electrochemical analysis, thermal analysis, separation analysis, and microscopy. The pharmaceutical industry is witnessing a growing demand for Raman spectroscopy to develop new drugs. Raman spectroscopy employs spectrometers and the spectroscopic technique to uncover the chemical structure, concentration, identity, and behavior of molecules in various forms. In pharmaceuticals, Raman spectroscopy is utilized for drug discovery by defining the structural composition of therapeutic drug agents and investigating intermolecular interactions. Post-approval, it ensures the correct compound’s manufacturing and guards against hazardous substances from packaging. Consumables, including funnels, flasks, syringes, and needles, are crucial for drug development and significantly contribute to market expansion due to recurring purchases for diverse testing purposes. Reagents and buffers are among the essential consumables, with their repeated usage in scientific tests and experiments. The variety of reagents required for different testing objectives presents an opportunity for consumables manufacturers to cater to end-users’ diverse needs. Technological advances in reaction buffers have resulted in heightened stability and longevity for reagents and enzymes, driving the growth of the laboratory analytical instruments and consumables segment and the market as a whole.

For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017-2021) – Download a Sample Report

Research Analysis

The scientific instrument market encompasses a wide range of tools used for measuring, analyzing, verifying, and understanding physical quantities in various sectors. Key product categories include microscopes for observing and examining samples at the microscopic level, spectrometers for identifying and quantifying materials based on their light interaction, X-ray diffraction for determining crystal structures, and thermal analyzers for studying material properties under temperature changes. Handheld and benchtop instruments, as well as portable versions, cater to field research and on-site analysis. Laboratories in pharmaceutical sectors, government, universities, and research institutions utilize these instruments for drug safety, automated solutions, and data analysis. In addition, clinical analyzers are essential in hospitals for public health emergencies and diagnostic purposes. Theoretical research and remodeling also benefit from these tools, ensuring accuracy and advancing scientific knowledge.

Market Research Overview

The scientific instrument market encompasses a wide range of products designed for measuring, analyzing, and verifying physical quantities in various fields. Key product categories include Microscopes (Product and Electron), Spectrometers (Handheld, Benchtop, and Portable), X-ray Diffraction, Thermal Analyzers, and various analyzers like Chromatographs and Particle Analyzers. These instruments find applications in laboratories, healthcare companies, retail and online sales, biotechnology, materials science, environmental science, private organizations, academic institutions, and pharmaceutical companies. Areas of focus include biomarker detection systems, drug development, molecular interactions, biological processes, disease mechanisms, genomics and proteomics, drug discovery, personalized healthcare, and quality control. Additionally, scientific instruments are used in aerospace engineering for cameras, celestial bodies, and planetary exploration, as well as in avionics technology and environmental monitoring. In the healthcare sector, instruments are used for medical diagnosis, treatment planning, infectious diseases, clinical laboratories, and cancer research. In the pharmaceutical sector, instruments play a crucial role in drug safety, automated solutions, data analysis, and pharmaceutical research. The market also includes startups, focusing on areas like drug safety, precision medicine, and automation. Instruments are used in various sectors like chromatographs, particle analyzers, scientific clinical analyzers, and for analyzing biological samples like blood, urine, and tissue. Instruments are used to measure and analyze glucose levels, cholesterol levels, and blood cell counts, among other physical quantities. The market also includes instruments for remodeling, theoretical research, and measuring various physical quantities. In summary, the scientific instrument market caters to a diverse range of applications and industries, enabling advancements in fields like biotechnology, healthcare, pharmaceuticals, and aerospace engineering.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

ProductLaboratory Analytical Instruments And ConsumablesMeasuring And Monitoring DevicesEnd-userPharmaceutical And Biotechnology CompaniesHospitals And Diagnostic LaboratoriesOthersGeographyNorth AmericaEuropeAsiaRest Of World (ROW)

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/scientific-instrument-market-size-is-set-to-grow-by-usd-19-96-billion-from-2024-2028–increasing-investments-in-drug-discovery-boost-the-market-technavio-302210020.html

SOURCE Technavio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Desay SV Reshapes the New Ecosystem of Smart Mobility

Published

on

By

SHANGHAI, April 27, 2025 /PRNewswire/ — On April 22, Desay SV unveiled 2030 development strategy, new mission and vision under the theme “Unlimited Intelligence”. The company simultaneously showcased Smart Solution 3.0, an AI-driven smart mobility solution designed for future transportation.

To be A New Paradigm

Following driver-assistance technologies are becoming increasingly widespread, high level driver-assistant from optional to must be for the industry. However, the industry still faces significant hurdles, including complex development processes, suboptimal user experience, weak value perception, and challenges in development turning into mass production.

Gao Dapeng emphasized that only a new paradigm can cross the industry’s chasm. Over the past five years, Desay SV has achieved a 34% CAGR in R&D investment, established 12 global R&D centers, and built a 4,200-strong engineering team. Desay SV has undergone a remarkable transformation from a technology reserve to a scaled application and a leader in the industry. This journey has been characterized by a relentless reinvention of outdated frameworks, systems, and models. 

In discussing future challenges, Gao Dapeng, Chairman of Desay SV, outlined Desay SV core value proposition: open for collaboration, insist on full-stack capability, and rapid implementation. Guided by the mission of “Creating Safe, Delightful and Sustainable Mobility” and the vision of “Smarter Mobility for All,” the company will expand technological capabilities, broaden ecosystem partnerships, and shape next-gen mobility solutions.

Enhancing the Full-Stack Capability for Continuous Advancement

Currently, 1 out of every 3 vehicles in China is equipped with Desay SV products and solutions – the market penetration driven by the company’s R&D innovation and ecosystem-building capabilities. With nearly four decades of technological dedication, Desay SV insists on shaping the underlying architecture with innovative synergies and achieving full-stack expertise in both hardware and software.

Addressing challenges including ill-defined user demands, complex industry collaboration, and escalating innovation costs in the AI era, Desay SV CEO Xu Jian presented a three-year solution termed “One Architecture + Three Businesses + Three Commitments”. The “One Architecture” is the integrated architecture covering the vehicle, road, and cloud; the “Three Businesses” represent the technological upgrades of the intelligent cabin, intelligent driving, and connected service. The “Three Commitments” encompass sustained investment in all-domain capability, multi-modal integration across value chains for ecosystem advancement, collaboration across R&D-to-manufacturing value chains to strengthen the industrial ecosystem and human-centric commitments to deliver all-encompassing intelligent mobility ecosystems.

Xu Jian emphasized that the AI variable will accelerate intelligent vehicle adoption. Desay SV maintains a triple-phase development cadence – mass production, pre-research, and technology reserves – to continuously roll out innovative products and technology solutions tailored to future mobility demands. While executing these foundational solutions, we’re exploring optimized and potential pathways for the future.

Crafting the Mobile Embodied Agent–Smart Solution 3.0

The release of “Desay SV Mobility Trends Analysis Report in the AI Era” provided cutting-edge insights. The report conducts an in-depth analysis of user profiles in the AI era, proposing six trends. The debut of Smart Solution 3.0 represents the systematic implementation of these AI mobility future trends.

Driven by AI advancements, Smart Solution 3.0 integrates over 150 cutting-edge technologies spanning spatial computing, neural augmentation, and ambient stealth intelligence. Through four innovative scenarios—Verdant Forest, Hyper Sense Activation, Sentinel Care and Comfort Mode—the system displays a human-vehicle-environment ecosystem characterized by multi-sensory interaction, deep emotional resonance, real-time biometric tracking, and context-aware risk prediction. This technological convergence promotes the accelerated evolution of intelligent vehicles into Mobile Embodied Agents.

In the AI-empowered mobility era, Desay SV will harness engineering prowess, cost-optimized solutions, and open ecosystem architecture to forge safe, delightful, and sustainable mobility experiences, advancing the vision of “Smarter Mobility for All” to catalyze the golden age of assisted driving systems.

About Desay SV

Desay SV (002920.SZ) is a leading mobility technology company with R&D and service branches in Germany, Japan, Singapore, Spain, USA, etc. The company focuses on efficiently integrating smart cabin, smart drive, and smart service. Relying on 39 years of accumulation, Desay SV has excelled in R&D, design, quality management, and intelligent manufacturing. Desay SV’s continuous innovation and comprehensive capabilities earn the long-term trust of global customers, including Chery, Geely, SAIC, Toyota, Volkswagen, Volvo, etc., and have helped it rank 74th in the Automotive News 2024 top 100 global auto parts suppliers. For more information, please visit Desay SV online at www.desaysv.com or follow us on: https://www.linkedin.com/company/13690363

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/desay-sv-reshapes-the-new-ecosystem-of-smart-mobility-302439051.html

SOURCE Desay SV

Continue Reading

Technology

When a British Influencer Meets the Canton Fair

Published

on

By

GUANGZHOU, China, April 26, 2025 /PRNewswire/ — “It looks like we are walking straight into the future.” said British influencer Jason talking to the camera at China Import and Export Fair, also widely known as the Canton Fair.

 

As the world’s largest trade exhibition, the 137th Canton Fair has attracted buyers from over 200 countries and regions, with over 30,000 companies participating in. All types of cutting-edge technologies created dazzling sparks in the lens of Jason at the Service Robots Zone.

In the smart home appliances section, Jason was drawn to a refrigerator that can “think”—it provides recipes based on ingredient inventory and even enables users to check its contents remotely via smartphone. In the new energy vehicle section, autonomous electric cars and swappable-battery scooters left Jason exclaiming, “This is the future of transportation!”

The significance of the Canton Fair goes far beyond an exhibition; it provides a stage for real-time global trade transactions. Every year, buyers from over 200 countries strike deals worth billions of dollars here, forging partnerships that shape global supply chains. “This is no ordinary trade show,” Jason said in his video. “As a global commerce hub, it showcases not just business opportunities but also the immense momentum behind ‘Made in China.'”

Jason’s video has attracted enthusiastic responses on international social media platforms, with many global netizens commenting, “Jason is the most enthusiastic explorer in China to share values of truth.” 

Want to experience the Canton Fair through Jason’s first-person perspective? Click on the video and join us on this journey of technology and commerce!

YouTube Link:https://www.youtube.com/watch?v=TvKvlB5qPOg

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/when-a-british-influencer-meets-the-canton-fair-302439038.html

SOURCE The 137th Canton Fair

Continue Reading

Technology

ChangAn Outlines 2030 Vision at “Vast Ocean Plan: United Towards the Peak”-Themed Overseas Partner Conference in Chongqing

Published

on

By

The Company is rapidly accelerating its global expansion with the goal of becoming a world-class automobile brand.

CHONGQING, China, April 26, 2025 /PRNewswire/ — ChangAn Automobile (“ChangAn” or “the Company”), an intelligent low-carbon mobility technology company, recently hosted the 2025 Overseas Partner Conference in Chongqing under the theme “Vast Ocean Plan: United Towards The Peak.” The event brought together more than 500 partners from over 70 countries discuss the Company’s global achievements and share its future roadmap. During the conference, ChangAn unveiled its “2030 Vision,” pledging over $10 billion in global investment. The Company aims to reach 5 million in global vehicle sales by 2030. ChangAn also set its sights on becoming one of the world’s top 10 automobile brands.

ChangAn’s global business strategy continues to advance with an expected 5 million vehicles worldwide and 1.2 million overseas by 2030

In his keynote at the 2025 conference, Zhu Huarong, Chairman of ChangAn Automobile, highlighted the Company’s progress over five years in new energy, intelligence, and global business. Global sales rose 34.2% to 2.684 million vehicles in 2024, with 735,000 new energy vehicles and 536,000 sold internationally. “From product exports to brand globalisation, we are strengthening global competitiveness with the dual drive of ‘long-termism plus localized operations,'” Mr. Zhu said. Over the next five years, ChangAn will target five key overseas markets and expand localised production, branding, and customer service.

ChangAn’s overseas sales ranked among the top 3 in China’s automobile exports in 2024

At the conference, Li Mingcai, Executive Vice President of ChangAn Automobile, highlighted key global milestones. The Company launched its first international NEV manufacturing base in Thailand and developed eight overseas production partnerships, reaching a capacity of 580,000 units. In 2024, ChangAn ranked among China’s top three auto exporters, with over 500,000 vehicles sold internationally and revenue surpassing $11 billion. The brand expanded into 20 new countries, entering over 100 globally, and now operates 1,150 sales channels. CHANG-AN, DEEPAL, and AVATR gained international recognition, with ChangAn joining the “BrandZ Top 50 Chinese Global Brands” just 14 months after launching the Vast Ocean Plan. “In the wave of anti-globalization, ChangAn Automobile has confirmed the strength of China’s smart manufacturing with nine consecutive years of export growth,” Mr. Li said.

The 2025 “dual-track” development plan will see 20 new cars launched internationally

Technological innovation remains at the core of ChangAn’s global strategy, said Executive Vice President Wang Xiaofei. The Company has invested over 114.8 billion yuan in R&D and established an international team of 18,000, including 5,000 software and AI specialists. Its 2025 plan includes a dual-track fuel and new energy strategy. Fossil-fuel vehicles will target markets in Central and South America, the Middle East and Africa, and Eurasia, while new energy vehicles will focus on Asia Pacific and Europe. ChangAn is building a unified global brand structure through CHANG-AN, DEEPAL, and AVATR, executing a “1+N” brand strategy — one global IP and multiple localised campaigns annually. Product-wise, 20 new global models (10 fuel, 10 NEVs) will be launched, including the CS75PLUS, DEEPAL S05, AVATR 07, and CHANG-AN Q07.

ChangAn remains confident and committed to future growth. Moving forward, the Company will focus on building a “competitiveness plus high quality” strategy, leveraging its core strengths and technology innovation to expand its footprint globally and further elevate its international influence.

View original content to download multimedia:https://www.prnewswire.com/news-releases/changan-outlines-2030-vision-at-vast-ocean-plan-united-towards-the-peak-themed-overseas-partner-conference-in-chongqing-302439041.html

SOURCE ChangAn Automobile

Continue Reading

Trending